Spatial biomarkers of response to eribulin plus pembrolizumab in patients with metastatic triple negative breast cancer in the ENHANCE-1 trial.
ENHANCE-1 试验中转移性三阴性乳腺癌患者对艾立布林加帕博利珠单抗治疗反应的空间生物标志物
期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-025-00791-2
Foong Yee Hoon, Wang Qi, Kearney Matthew, Le Hortense, Guo Hua, Chen Diane, Politis Michelle Garlin, Connelly Courtney F, Kalinsky Kevin, Vanguri Rami S, Connolly Eileen P
